December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Po Hien Ear: Honored to represent UI Holden Comprehensive Cancer Center Neuroendocrine Tumor Models at Yale Cancer Center
Oct 20, 2024, 18:06

Po Hien Ear: Honored to represent UI Holden Comprehensive Cancer Center Neuroendocrine Tumor Models at Yale Cancer Center

Po Hien Ear shared on X:

“I’m so honored to represent University of Iowa Surgery, UI Holden Comprehensive Cancer Center Neuroendocrine Tumor Models at Yale Cancer Center today!

Thank you so much Dr Pamela Kunz for this amazing opportunity!

I can’t wait to get started with our collaboration projects with Yale Cancer Center team!”

Po Hien Ear

Po Hien Ear: Honored to represent UI Holden Comprehensive Cancer Center Neuroendocrine Tumor Models at Yale Cancer Center

Pamela Hunz shared this post on X, adding:

“It was such a pleasure to host you, Po Hien Ear! I look forward to future collaborations! ”

Pamela Kunz is an Associate Professor of Medicine in the Division of Oncology at Yale School of Medicine, Director of the Center for Gastrointestinal Cancers at Yale Cancer Center and Smilow Cancer Hospital. She was formerly the director of the Stanford Neuroendocrine Tumor Program, Leader of the Endocrine Oncology Research Group, and Director of the Neuroendocrine Tumor Fellowship.

Dr. Kunz is the President of the North American Neuroendocrine Tumor Society (NANETS) and Chair of the Neuroendocrine Tumor Taskforce of the NCI. In addition, she has emerged as a leading voice for promoting gender equity in the medical workforce and has been appointed as the Vice Chief for DEI for the Section of Medical Oncology at Yale Cancer Center.

Po Hien Ear is an Assistant Professor in the Department of Surgery at the University of Iowa Roy J. and Lucille A. Carver College of Medicine. Her research focuses on neuroendocrine tumors, developing new technologies for studying next-generation cancer models, precision medicine, the identification, use of biomarkers and serotonin metabolism in cancer.